The Indian veterinary healthcare market is experiencing unprecedented growth in 2025, projected to reach INR 51,185 crore (USD 6.13 billion) by 2033 with a robust CAGR of 12.20%. This surge is driven by increasing pet ownership, expanding livestock farming, and heightened awareness about animal health across both urban and rural India. Among the Top Veterinary Products Companies in India 2025, several stand out for their innovation, product quality, and market reach, with Vetraise Remedies emerging as a notable player in the specialized veterinary formulations segment. The industry continues to benefit from strong government support, technological advancements, and evolving regulations aimed at standardizing veterinary practices nationwide.
The veterinary pharmaceutical industry in India has transformed dramatically over recent years, establishing itself as one of the fastest-growing segments within the healthcare sector. As of 2024, the market was valued at approximately USD 2.01 billion, with projections indicating continued strong growth throughout 2025 and beyond. This expansion has been fueled by multiple factors, including the rising adoption of companion animals, increased investment in livestock farming, and greater awareness of animal welfare issues.
The production animal segment continues to dominate the market, accounting for 83.04% of the total market share in 2023, highlighting the significant role of livestock health in India’s agricultural economy. Within this segment, the dairy sector remains the largest contributor, having registered a 13% growth due to increased milk consumption, which has positively affected the usage of animal health products to maintain health and productivity.
Companion animal care has emerged as another significant growth driver, with this segment registering an exceptional growth rate of over 36.6% in recent years. This remarkable expansion reflects the growing human-pet bond in Indian society and increased spending on pet healthcare, particularly in urban areas where pet ownership has become increasingly common.
More than 50% of the Indian Animal Health market is contributed by the top 10 companies that have established research and development capabilities, marketing networks, and robust distribution strengths. These companies have positioned themselves strategically to capitalize on the growing demand for quality veterinary healthcare products.
Vetnation Pharma has established itself as one of the top veterinary companies in India for 2024, particularly recognized for its high-quality vaccines and veterinary medicines. As a pioneer in veterinary healthcare, the company focuses on animal health and productivity, especially in livestock, backed by strong research capabilities and WHO-GMP certification.
Hester Biosciences has demonstrated consistent financial performance, with revenue from operations reaching Rs 283.46 crore in March 2024, up from Rs 249.09 crore in March 2023, representing a year-over-year growth of approximately 13.8%. This financial strength positions the company as a significant player in the veterinary products market for 2025.
Several regional players comprising small and medium-sized generic companies have shown aggressive growth trends and entrepreneurship in recent years. The market has also witnessed the entry of many new Indian and multinational companies, either directly or through equity holdings, contributing positively to the overall competitive landscape.
Vetraise Remedies has emerged as a significant player in India’s veterinary pharmaceutical landscape in 2025. Located in Panchkula, this ISO 9001-2008 certified company has built a reputation as a leading manufacturer and supplier of veterinary formulations, including bolus, injections, oral liquids, poultry and cattle feed supplements, sprays, and mineral mixtures.
As a division of Hi-cure Biotech, Vetraise Remedies has positioned itself as a key player offering a wide range of products for both companion animals and livestock. Their portfolio spans from vaccines and antibiotics to anti-parasitic treatments, addressing the evolving needs of veterinarians and livestock farmers across the country.
What distinguishes Vetraise Remedies is its commitment to quality and affordability. The company utilizes WHO and GMP-approved high-quality materials in its manufacturing processes, ensuring that its products meet international standards while remaining accessible to a wide customer base. Their feed supplements undergo rigorous testing and trials, guaranteeing effectiveness and safety for animals.
The company operates through a PCD (Propaganda Cum Distribution) pharma franchise model, providing business opportunities for investors interested in entering the veterinary products market. This approach has helped Vetraise Remedies expand its market reach while maintaining control over product quality and brand reputation.
Address : Ground Floor, Shop No. 8-9, Guru Kripa Complex, Palam Enclave, Zirakpur, SAS Nagar, Punjab – 140603
Address : Khasra No. 14//15/2, 14//15/3, Nanhera Road, Kuldeep Nagar, Near Shri Hari Nath Mandir, Ambala Cantt – 133014, Haryana, India
Address : Civil Aerodrome Post, Coimbatore – 641014, Tamil Nadu, India
Address : Plot No. 286, Industrial Area Phase-1, Panchkula, Haryana, India
Address : Plot No. 295, Industrial Area Phase-2, Panchkula – 134109, Haryana, India
This comprehensive overview reflects the current veterinary PCD pharma franchise landscape, highlighting its business model, benefits, operational requirements, and market potential.
Vetraise Remedies has strategically diversified its product portfolio to serve multiple animal segments, including:
This segmentation strategy allows the company to address the specific needs of different animal categories, positioning it as a comprehensive solution provider in the veterinary healthcare space.
The veterinary healthcare industry in India is being shaped by several key trends and drivers that provide valuable insights for stakeholders in the sector:
There is a growing interest in preventive healthcare in India’s animal husbandry industry. Livestock farmers and pet owners are increasingly adopting disease prevention measures, driven by awareness of zoonotic diseases and the potential financial losses resulting from infections. Vaccination initiatives, deworming, and parasite control efforts are gaining momentum, supported by both government programs and private investment.
The growth in veterinary diagnostics, including point-of-care solutions and rapid tests, enhances the early detection of diseases, allowing for more effective treatment and management. Digital platforms delivering telemedicine services and veterinary consultancy are making preventive care more accessible, particularly in rural and semi-urban areas.
Government participation has become a significant market driver, with initiatives ranging from regulatory changes to veterinary practices and testing of veterinary drugs. In August 2023, the Department of Animal Husbandry and Dairying finalized Standard Veterinary Treatment Guidelines covering 274 animal diseases across multiple species, aiming to standardize veterinary practices nationwide.
These guidelines promote the stewardship of veterinary drugs to inhibit irrational treatment practices and reduce the risk of antimicrobial resistance among animals. Further regulatory developments, such as the Indian Pharmacopoeia Commission’s decision to waive obsolete veterinary vaccines safety tests, align India’s practices with international standards.
Different animal segments within the veterinary healthcare market are experiencing varying growth rates:
These differential growth rates highlight the importance of targeted product development and marketing strategies for companies operating in the veterinary healthcare space.
Looking ahead to the remainder of 2025 and beyond, several factors are likely to shape the future of India’s veterinary products industry:
The Indian veterinary healthcare industry is experiencing major developments in pharmaceuticals and biologics, improving treatment effectiveness. Innovations in drug delivery systems, vaccine technologies, and diagnostic tools are creating new opportunities for companies to enhance their product offerings and market competitiveness.
The growth of veterinary clinics and hospitals, particularly in tier-2 and tier-3 cities, is expanding access to professional animal healthcare services. Companies with strong distribution networks that can reach these emerging markets stand to gain significant competitive advantages in the coming years.
Increased focus on sustainable and ethical practices in animal husbandry is influencing product development and marketing strategies. Companies that can demonstrate commitment to environmental responsibility and animal welfare are likely to resonate with increasingly conscious consumers and stakeholders.
The veterinary products industry in India is at an exciting inflection point in 2025, characterized by robust growth, technological innovation, and evolving consumer preferences. With the market projected to reach USD 6.13 billion by 2033, companies that can adapt to changing demands and regulatory landscapes will be well-positioned to capture market share.
Vetraise Remedies, with its comprehensive product portfolio, quality-focused manufacturing practices, and strategic market approach, exemplifies the kind of company that is helping shape the future of animal healthcare in India. As the industry continues to evolve, data-driven decision-making and customer-centric product development will be key differentiators for success in this dynamic market.
For veterinarians, pet owners, and livestock farmers, the expanding range of high-quality veterinary products from companies like Vetraise Remedies represents an opportunity to enhance animal health outcomes and productivity, contributing to the overall growth and welfare of India’s animal population.
If you are interested in getting any query or details regarding Top Veterinary Products Companies in India 2025, then you can contact us on below information.
